Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Document:USA FDA - E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1): Guidance for Industry March 2018: Difference between revisions

From GxPlex

Jump to: navigation, search
← Older editNewer edit →
m 1 revision imported
Migrate to Template:DocumentData for PageForms (GxPlexBot)
Line 1: Line 1:
<noinclude>{{#set:
{{DocumentData
|DocReference=USA  FDA - E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1):
Guidance for Industry  March 2018
|DocValidityArea=USA
|DocScopes=G
|DocName=FDA - E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1):
Guidance for Industry
|DocVersion=March 2018
|DocStatus=Current
|DocType=Official recommendation
|DocLanguage=EN
|DocDescription=GUIDANCE DOCUMENT
 
E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1)
|DocRestricted=No
|DocSubmittedBy=Florian Adragna
|DocContributors=
}}</noinclude>
 
{{DocumentBox
|reference=USA  FDA - E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1):  
|reference=USA  FDA - E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1):  
Guidance for Industry  March 2018
Guidance for Industry  March 2018

Revision as of 12:54, 16 July 2026


Document information
Reference USA FDA - E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1):

Guidance for Industry March 2018

Validity area USA
Scope(s) G
Document name FDA - E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1):

Guidance for Industry

Version / Revision March 2018
Status Current
Document type Official recommendation
Language(s) EN
Description GUIDANCE DOCUMENT

E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1)

Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors

References

 ScopeDocument partLanguagePreview
USA FDA - E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1): Guidance for Industry March 2018 -G-ENThis guidance represents the current thinking of the Food and Drug Administration (FDA or Agency) on this topic. It does not establish any rights for …


References

Reference Scope Document part Language Preview
Reference:USA FDA - E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1): Guidance for Industry March 2018 - G - EN This guidance represents the current thinking of the Food and Drug Administration (FDA or Agency) on this topic. It does not establish any rights for any person and is not binding on FDA or the ...
Retrieved from "https://gxplex.org/index.php?title=Document:USA_FDA_-_E6(R2)_Good_Clinical_Practice:_Integrated_Addendum_to_ICH_E6(R1):_Guidance_for_Industry_March_2018&oldid=15997"